XML 46 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK BASED COMPENSATION PLANS
9 Months Ended
Mar. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE 8 – STOCK BASED COMPENSATION PLANS
 
The Company follows Accounting Standard Codification (ASC) Topic 718 “Compensation – Stock Compensation”, which addresses accounting for equity-based compensation arrangements, including employee stock options and restricted stock units. 
 
Please refer to Note 16 – Stock Based Compensation Plans in the Company's Form 10-K for the year ended June 30, 2012 for more detail information on the Company’s stock-based compensation plans.
 
During the three months ended March 31, 2013 and 2012, the Company recorded stock option compensation cost of $80,000 and $55,000, respectively, related to the issuance of stock options. During the nine months ended March 31, 2013 and 2012, the Company recorded stock option compensation cost of $271,000 and $153,000, respectively, related to the issuance of stock options. As of March 31, 2013, there was a total of $390,000 of unamortized compensation related to stock options which is expected to be recognized over the weighted-average period of 5 years.
 
Option-pricing models require the input of various subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The expected stock price volatility is based on analysis of the Company’s stock price history.   The Company has selected to use the simplified method for estimating the expected term. The risk-free interest rate is based on the U.S. Treasury interest rates whose term is consistent with the expected life of the stock options. No dividend yield is included as the Company has not issued any dividends and does not anticipate issuing any dividends in the future.
 
 
The following table summarizes the stock options activity from June 30, 2011 through March 31, 2013:
 
 
 
 
 
Number of
 
Weighted Average
 
Weighted Average
 
Aggregate
 
 
 
 
 
Shares
 
Exercise Price
 
Remaining Life
 
Intrinsic Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oustanding at
 
June 30, 2011
 
 
162,000
 
$
11.02
 
 
6.48 years
 
$
2,252,000
 
Granted
 
 
 
 
95,000
 
 
20.04
 
 
 
 
 
 
 
Exercised
 
 
 
 
-
 
 
-
 
 
 
 
 
 
 
Forfeited
 
 
 
 
-
 
 
-
 
 
 
 
 
 
 
Exchanged
 
 
 
 
(15,000)
 
 
13.72
 
 
 
 
 
 
 
Oustanding at
 
June 30, 2012
 
 
242,000
 
$
14.55
 
 
7.46 years
 
$
2,050,000
 
Exercisable at
 
June 30, 2012
 
 
87,000
 
$
11.48
 
 
4.92 years
 
$
1,046,000
 
Vested and Expected to vest at
 
June 30, 2012
 
 
242,000
 
$
14.55
 
 
7.46 years
 
$
2,050,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oustanding at
 
June 30, 2012
 
 
242,000
 
$
14.55
 
 
7.46 years
 
$
2,050,000
 
Granted
 
 
 
 
-
 
 
-
 
 
 
 
 
 
 
Exercised
 
 
 
 
-
 
 
-
 
 
 
 
 
 
 
Forfeited
 
 
 
 
-
 
 
-
 
 
 
 
 
 
 
Exchanged
 
 
 
 
-
 
 
-
 
 
 
 
 
 
 
Oustanding at
 
March 31, 2013
 
 
242,000
 
$
14.55
 
 
6.71
 
$
2,252,000
 
Exercisable at
 
March 31, 2013
 
 
125,000
 
$
12.48
 
 
5.3
 
$
1,418,000
 
Vested and Expected to vest at
 
March 31, 2013
 
 
242,000
 
$
14.55
 
 
6.71
 
$
2,252,000
 
 
The table below summarizes the restricted stock units (RSUs) granted and outstanding.
 
 
 
 
 
 
 
Weighted Average
 
 
 
 
 
 
 
Grant Date
 
 
 
 
 
Number of RSUs
 
Fair Value
 
RSUs outstanding as of
 
June 30, 2011
 
 
20,884
 
$
16.14
 
Granted
 
 
 
 
8,245
 
 
24.94
 
Converted to common stock
 
 
 
 
(20,884)
 
 
16.14
 
RSUs outstanding as of
 
June 30, 2012
 
 
8,245
 
 
24.94
 
Granted
 
 
 
 
-
 
 
-
 
Converted to common stock
 
 
 
 
(4,125)
 
 
24.94
 
RSUs outstanding as of
 
March 31, 2013
 
 
4,120
 
$
24.94
 
  
On July 1 of every year, as part of the Stock Compensation Plan for Non-employee Directors, each non-employee director received an automatic grant of a number of shares of Company’s Common Stock equal in value to $22,000 ($88,000 total recorded as stock compensation expense) based on 100% of the fair market value of the Company’s stock on the day of grant. During the nine months ended March 31, 2013 and 2012, the four non-employee directors of the Company received a total grant of 3,528 and 3,532 shares of common stock.